MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 210 filers reported holding MEDICINES CO in Q2 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2018 | $3,000 | -25.0% | 102 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | – | 102 | +1940.0% | 0.00% | – |
| Q1 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 5 | -95.7% | 0.00% | – |
| Q3 2017 | $4,000 | 0.0% | 115 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -33.3% | 115 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | +50.0% | 115 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | +33.3% | 115 | +47.4% | 0.00% | – |
| Q3 2016 | $3,000 | – | 78 | +1460.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 5 | -79.2% | 0.00% | – |
| Q4 2015 | $1,000 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |